Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
Oncology - Drug Trials For Money - Paid Clinical Trials

Oncology

Headache Relief Shampoo Voted #1 Best New Product in 2019

Dr. D’s Medicated Headache Relief Shampoo is now available. This medicated shampoo will help alleviate headaches simply by soaking it on your head. Finding relief from minor to severe headaches shouldn’t always involve reaching for a bottle of pills. Dr. D is here to give you another option. Our proprietary formula will leave your head feeling better.

BUY NOW! http://headachereliefshampoo.com/product/headache-relief-shampoo/

January 1, 2019 / by / in
Phase I Human Analytics (HALO) Study
Conditions:   Cardiovascular Diseases;   Cancer;   Dementia;   Traumatic Brain Injury
Intervention:   Other: no interventions will be performed (observational)
Sponsor:   Desert Medical Imaging
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 22, 2022 / by / in
Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer
Condition:   Non-Small Cell Lung Cancer
Intervention:  
Sponsor:   Memorial Sloan Kettering Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 22, 2022 / by / in
Cabozantinib for Patients With Recurrent or Progressive Meningioma
Condition:   Meningioma
Intervention:   Drug: Cabozantinib
Sponsors:   Baptist Health South Florida;   Exelixis
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 22, 2022 / by / in
Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families
Conditions:   Leukemia;   Non Hodgkin Lymphoma
Intervention:   Other: Interview
Sponsors:   University of Colorado, Denver;   Children’s Hospital Colorado
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 22, 2022 / by / in
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
Condition:   Colorectal Cancer
Interventions:   Drug: XL092;   Drug: Atezolizumab;   Drug: Regorafenib
Sponsors:   Exelixis;   Roche Pharma AG
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 22, 2022 / by / in
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Conditions:   Metastatic Prostate Cancer;   Neuroendocrine Prostate Cancer
Intervention:   Drug: ORIC-944
Sponsor:   ORIC Pharmaceuticals
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 22, 2022 / by / in
Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia
Condition:   Oropharyngeal Dysphagia
Interventions:   Biological: Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR);   Other: Placebo
Sponsors:   University of California, Davis;   California Institute for Regenerative Medicine (CIRM);   Cook MyoSite
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 17, 2022 / by / in
Study To Evaluate The Safety, Tolerability And Immunogenicity Of 4 mg Of ITI-3000 In Patients With Polyomavirus-Positive Merkel Cell Carcinoma (MCC)
Condition:   Merkel Cell Carcinoma
Intervention:   Drug: ITI-3000
Sponsor:   Immunomic Therapeutics, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 17, 2022 / by / in
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
Conditions:   Lung Cancer;   Lung Cancer Metastatic;   Brain Metastases;   Brain Metastases, Adult;   Small-cell Lung Cancer;   Small Cell Lung Carcinoma
Interventions:   Radiation: Stereotactic Radiosurgery;   Procedure: Cerebrospinal fluid collection
Sponsor:   Memorial Sloan Kettering Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 16, 2022 / by / in
An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk
Conditions:   BRCA1 Mutation;   POLD1 Gene Mutation;   CDKN2A Mutation;   BRCA2 Mutation;   POLE Gene Mutation;   APC Gene Mutation;   ATM Gene Mutation;   MLH1 Gene Mutation;   BARD1 Gene Mutation;   MSH2 Gene Mutation;   BRIP1 Gene Mutation;   MSH6 Gene Mutation;   CHEK2 Gene Mutation;   PMS2 Gene Mutation;   PALB2 Gene Mutation;   EPCAM Gene Mutation;   RAD51C Gene Mutation;   BMPR1A Gene Mutation;   RAD51D Gene Mutation;   SMAD4;   PTEN Gene Mutation;   GREM1
Interventions:   Other: Intervention Arm At-risk Relative/ARR Contacts;   Behavioral: Multidimensional Impact of Cancer Risk Assessment questionnaire;   Behavioral: Satisfaction with Decision Scale;   Behavioral: Cancer Prevention Behaviors uptake and intentions;   Behavioral: Genetics Knowledge;   Behavioral: Modified version of the Acceptability E-scale
Sponsor:   Memorial Sloan Kettering Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 16, 2022 / by / in